Cardiff Oncology, Inc. (CRDF) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 41K | 243K | 120K | 121K | 109K | 151K | 165K | 163K | 205K | 156K | 141K | 108K |
| Revenue Growth % | -62.39% | 60.93% | -27.27% | -25.77% | -46.83% | -3.21% | 17.02% | 50.93% | 146.99% | 21.88% | 51.61% | 18.68% |
| Cost of Goods Sold | 221K | 0 | 0 | 11.58M | 0 | 0 | 9.64M | 105K | 102K | 103K | 107K | 0 |
| COGS % of Revenue | 539.02% | - | - | 9570.25% | - | - | 5842.42% | 64.42% | 49.76% | 66.03% | 75.89% | - |
| Gross Profit | -180K | 243K | 120K | -11.46M | 109K | 151K | -9.47M | 58K | 103K | 53K | 34K | 108K |
| Gross Margin % | -439.02% | 100% | 100% | -9470.25% | 100% | 100% | -5742.42% | 35.58% | 50.24% | 33.97% | 24.11% | 100% |
| Gross Profit Growth % | -265.14% | 60.93% | 101.27% | -19856.9% | 5.83% | 184.91% | -27967.65% | -46.3% | 24.1% | -58.59% | -63.44% | 18.68% |
| Operating Expenses | 12.67M | 8.07M | 12.09M | 3.32M | 14.49M | 12.72M | 3.13M | 12.6M | 11.04M | 10.38M | 10.85M | 12.32M |
| OpEx % of Revenue | 30902.44% | 3320.99% | 10078.33% | 2742.15% | 13294.5% | 8425.83% | 1894.55% | 7731.9% | 5383.41% | 6657.05% | 7697.87% | 11403.7% |
| Selling, General & Admin | 6.13M | 3M | 3.9M | 0 | 4.01M | 3.01M | 0 | 3.21M | 3.03M | 2.73M | 2.94M | 4.3M |
| SG&A % of Revenue | 14941.46% | 1232.51% | 3247.5% | - | 3682.57% | 1994.04% | - | 1972.39% | 1477.07% | 1746.79% | 2084.4% | 3977.78% |
| Research & Development | 6.76M | 5.08M | 8.2M | 11.58M | 10.48M | 9.71M | 9.64M | 9.49M | 8.01M | 7.76M | 8.02M | 8.02M |
| R&D % of Revenue | 16500% | 2088.48% | 6830.83% | 9570.25% | 9611.93% | 6431.79% | 5842.42% | 5823.93% | 3906.34% | 4976.28% | 5689.36% | 7425.93% |
| Other Operating Expenses | -221K | 0 | 0 | -1000K | 0 | 0 | -1000K | -105K | 0 | -103K | -107K | 0 |
| Operating Income | -12.85M | -7.83M | -11.97M | -14.78M | -14.38M | -12.57M | -12.6M | -12.54M | -10.93M | -10.33M | -10.82M | -12.21M |
| Operating Margin % | -31341.46% | -3220.99% | -9978.33% | -12212.4% | -13194.5% | -8325.83% | -7636.97% | -7696.32% | -5333.17% | -6623.08% | -7673.76% | -11303.7% |
| Operating Income Growth % | 10.65% | 37.74% | 4.98% | -17.79% | -31.55% | -21.68% | -16.46% | -2.76% | 9.28% | -10.01% | -20.32% | -16.9% |
| EBITDA | -12.63M | -7.6M | -11.48M | -14.68M | -14.15M | -12.48M | -12.5M | -12.44M | -10.83M | -10.23M | -10.71M | -12.11M |
| EBITDA Margin % | -30802.44% | -3129.22% | -9566.67% | -12134.71% | -12985.32% | -8262.25% | -7575.76% | -7631.9% | -5283.41% | -6557.05% | -7597.87% | -11212.96% |
| EBITDA Growth % | 10.77% | 39.05% | 8.16% | -18.03% | -30.68% | -21.97% | -16.68% | -2.73% | 9.45% | -9.92% | -20.21% | -16.39% |
| D&A (Non-Cash Add-back) | 221K | 223K | 494K | 94K | 228K | 96K | 101K | 105K | 102K | 103K | 107K | 98K |
| EBIT | -12.85M | -7.83M | -11.26M | -14.78M | -14.38M | -12.57M | -12.6M | -12.54M | -10.93M | -10.33M | -10.82M | -12.21M |
| Net Interest Income | 506K | 612K | 716K | 835K | 941K | 787K | 741K | 805K | 926K | 1.01M | 1.07M | 1.05M |
| Interest Income | 506K | 612K | 716K | 835K | 941K | 787K | 741K | 805K | 926K | 1.01M | 1.07M | 1.05M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 505K | 611K | 716K | 834K | 948K | 785K | 746K | 767K | 922K | 995K | 1.09M | 1.06M |
| Pretax Income | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M |
| Pretax Margin % | -30124.39% | -2969.55% | -9381.67% | -11523.14% | -12324.77% | -7805.96% | -7184.85% | -7225.77% | -4883.41% | -5985.26% | -6901.42% | -10324.07% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M |
| Net Margin % | -30124.39% | -2969.55% | -9381.67% | -11523.14% | -12324.77% | -7805.96% | -7184.85% | -7225.77% | -4883.41% | -5985.26% | -6901.42% | -10324.07% |
| Net Income Growth % | 8.06% | 38.78% | 5.04% | -18.38% | -34.19% | -26.24% | -21.83% | -5.63% | 10.8% | -7.36% | -13.53% | -6.77% |
| Net Income (Continuing) | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.18 | -0.11 | -0.17 | -0.21 | -0.28 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 |
| EPS Growth % | 35.71% | 56% | 32% | 19.23% | -27.27% | -19.05% | -13.64% | -4% | 4.35% | -16.67% | -15.79% | -4.17% |
| EPS (Basic) | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 | -0.25 | -0.25 | -0.26 | -0.22 | -0.21 | -0.22 | -0.25 |
| Diluted Shares Outstanding | 68.35M | 66.84M | 66.88M | 66.53M | 47.65M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M |
| Basic Shares Outstanding | 68.35M | 66.84M | 66.88M | 66.53M | 66.52M | 47.65M | 46.87M | 44.83M | 44.68M | 44.68M | 44.68M | 44.68M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |